- ISIN
- US0234361089
- CUSIP
- 023436108
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- IPO Date
- Aug 17, 1994
Highlights
- Market Cap
- $3.32B
- Enterprise Value
- $3.50B
- EPS (TTM)
- $4.56
- PE Ratio
- 22.16
- Total Revenue (TTM)
- $2.40B
- Gross Profit (TTM)
- $1.26B
- EBITDA (TTM)
- $164.66M
- Year Range
- $93.75 - $101.02
- ROA (TTM)
- 6.76%
- ROE (TTM)
- 12.15%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
AMED Performance Chart
Loading charts...
Returns By Period
Amedisys, Inc.
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 0.13%
- 1M
- 5.25%
- YTD
- 11.16%
- 6M
- 11.43%
- 1Y
- 28.20%
- 3Y*
- 21.12%
- 5Y*
- 12.66%
- 10Y*
- 13.75%
AMED Monthly Returns History
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 1.88% | -0.54% | 0.68% | 2.45% | -0.87% | 4.59% | 0.21% | 2.42% | 11.23% | ||||
| 2024 | -0.83% | -1.33% | -0.92% | -0.12% | -0.98% | 0.71% | 6.81% | -0.04% | -1.53% | -1.98% | -3.37% | -0.68% | -4.49% |
| 2023 | 15.71% | -4.87% | -20.01% | 9.18% | -5.44% | 20.43% | -0.66% | 3.20% | -0.37% | -2.04% | 2.28% | 1.58% | 13.79% |
| 2022 | -16.54% | 18.61% | 7.52% | -25.91% | -9.20% | -9.31% | 14.01% | -1.17% | -18.29% | 0.83% | -6.66% | -8.29% | -48.39% |
| 2021 | -2.05% | -11.72% | 4.40% | 1.91% | -4.25% | -5.20% | 6.41% | -29.61% | -18.72% | 13.57% | -17.53% | 15.92% | -44.81% |
Benchmark Metrics
Amedisys, Inc. has an annualized alpha of 27.07%, beta of 0.70, and R2 of 0.04 versus S&P 500 Index. Calculated based on daily prices since August 19, 1994.
- This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (74.87%) than losses (66.41%) - typical of diversified or defensive assets.
- R2 of 0.04 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 27.07%
- Beta
- 0.70
- R²
- 0.04
- Upside Capture
- 74.87%
- Downside Capture
- 66.41%
Return for Risk
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Amedisys, Inc. (AMED) and compare them to S&P 500 Index.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Amedisys, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Amedisys, Inc. was 91.23%, occurring on May 6, 1999. Recovery took 1132 trading sessions.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
1999 bear market1999 | -91.23%May 1999 | 3y 10mo | 4y 6mo | 8y 4moJul 1995 - Nov 2003 |
2012 bear market2012 | -85.53%Jan 2012 | 3y 5mo | 6y 2mo | 9y 8moAug 2008 - Apr 2018 |
2023 bear market2023 | -77.79%Mar 2023 | 2y 1mo | — | 5y 4moJan 2021 - now |
2004 bear market2004 | -37.89%Aug 2004 | 1mo 2d | 3mo 4d | 4mo 6dJul 2004 - Nov 2004 |
2006 bear market2006 | -34.29%Feb 2006 | 2mo 11d | 1y 2mo | 1y 4moDec 2005 - May 2007 |
Drawdown Indicators
| AMED | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -56.78% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -9.10% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | — | 0.00% | — |
Average DrawdownAverage peak-to-trough decline | — | -10.72% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 1.97% | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Amedisys, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Amedisys, Inc. is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for AMED, comparing it with other companies in the Medical Care Facilities industry. Currently, AMED has a P/E ratio of 22.2. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for AMED relative to other companies in the Medical Care Facilities industry. Currently, AMED has a P/S ratio of 1.4. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for AMED in comparison with other companies in the Medical Care Facilities industry. Currently, AMED has a P/B value of 2.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with AMED
Add Amedisys, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with AMED